# Rasagiline

NDC: 33342-308
Generic name: Rasagiline
Labeler / Manufacturer: Macleods Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20240629

FDA application: ANDA208866

## Active ingredients

- RASAGILINE MESYLATE: .5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"33342-308"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=33342-308
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e8771c7e-5ecf-47dc-a0fd-4d12e85631a6